";s:4:"text";s:5054:" Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Because the interrelationship between alcohol dependence, depression and suicidality is well-recognised and complex, it is recommended that alcohol-dependent patients, including those treated with acamprosate, be monitored for such symptoms.
Medicinal forms There can be variation in the licensing of different medicines containing the same drug. Treatment with Acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support.The efficacy of Acamprosate calcium in promoting abstinence has not been demonstrated i… There is no information available on the concomitant administration of acamprosate with diuretics.There are no adequate data from the use of acamprosate in pregnant women. Administering acamprosate with food diminishes the bioavailability of the drug compared with its administration in the fasting state. Check with your doctor immediately if any of the following side effects occur while taking acamprosate: More common.
- In subjects weighing less than 60kg, 4 tablets divided into three daily doses with meals (2 tablets in the morning, 1 at noon and 1 at night).
Acamprosate (calcium-acetyl homotaurinate) is a synthetic derivative of taurine that is used to treat relapse in alcohol-dependent patients. Acamprosate suppresses the ADE in two-bottle choice and operant self-administration designs. It may not help you if you are also addicted to other substances besides alcohol.Acamprosate may also be used for purposes not listed in this medication guide.You should not use acamprosate if you have severe kidney disease.You should not use acamprosate if you are allergic to it, or if you have severe kidney disease.To make sure acamprosate is safe for you, tell your doctor if you have any type of kidney problem.You may have thoughts about suicide while taking acamprosate. Non-clinical studies suggest that acamprosate has little or no abuse potential. The risk may be greater in people who have had these thoughts or actions in the past. Along with its needed effects, acamprosate may cause some unwanted effects. Treatment with acamprosate should be initiated as soon as possible after the withdrawal period and should be maintained if the patient relapses.Acamprosate does not prevent the harmful effects of continuous alcohol abuse. In clinical trials, acamprosate has been safely administered in combination with antidepressants, anxiolytics, hypnotics and sedatives, and non-opioid analgesics.No change in the frequency of clinical and/or biological adverse reactions has been shown when acamprosate is used concomitantly with disulfiram, oxazepam, tetrabamate or meprobamate.Pharmacokinetic studies have been completed and show no interaction between acamprosate and diazepam, imipramine. It should be combined with counselling. The following definitions apply to the frequency terminology used hereafter: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data). In the reported cases, the only symptom which can be reasonably related to overdose is diarrhoea. Swallow it whole.Take this medicine for the full prescribed length of time, even if you relapse and drink alcohol. Acamprosate should not be administered to children, adolescents and the elderly. It is not known whether acamprosate is excreted in human milk. In animal studies, no adverse effects on fertility were observed. Your family or other caregivers should also be alert to changes in your mood or symptoms.It is not known whether acamprosate will harm an unborn baby. By continuing to browse the site you are agreeing to our policy on the use of cookies. Disorders of phosphorus/calcium metabolism have been observed including diarrhoea, soft tissue calcification, renal and cardiac lesions.